Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06422936
Title Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) (SPOTLIGHT204)
Acronym SPOTLIGHT204
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Highlight Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | ESP


No variant requirements are available.